The patients who were given the drug turned negative for the virus after an average of four days of testing positive.
Chinese medical experts have announced that a drug in Japan used to treat influenza appears to also be effective on coronavirus patients.
The drug is called favipiravir, which was developed by Fujifilm Toyama Chemical, a subsidiary of Fujifilm. It had allegedly produced promising outcomes in trials made in Wuhan and Shenzen, China that involved 340 patients.
“It has a high degree of safety and is clearly effective in treatment,” Zhang Xinmin, an official at China’s science and technology ministry, told reporters on Tuesday.
The patients who were given the drug turned negative for the virus after an average of four days of testing positive. Additionally, the patients’ X-rays confirmed that there were improvements in their lung condition.
However, Fujifilm has yet to comment on the claims.
To read the original story, click here.